Literature DB >> 21251008

Structural basis of influenza virus neutralization.

Thomas Han1, Wayne A Marasco.   

Abstract

Although seasonal influenza vaccines play a valuable role in reducing the spread of virus at the population level, ongoing viral evolution to evade immune responses remains problematic. No current vaccines elicit enduring protection in the face of emerging and re-emerging influenza viruses that are rapidly undergoing antigenic drift. Eliciting broadly cross-neutralizing antibody (nAb) responses against influenza virus is a crucial goal for seasonal and pandemic influenza vaccine preparation. Recent three-dimensional structure information obtained from crystallization of influenza antigens in complex with nAbs has provided a framework for interpreting antibody-based viral neutralization that should aid in the design of vaccine immunogens. Here, we will review current knowledge of the structure-based mechanisms contributing to the neutralization and neutralization escape of influenza viruses. We will also explore the potential for this structure-based approach to overcome the obstacles in developing the highly desired "universal" influenza vaccine.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251008      PMCID: PMC3062959          DOI: 10.1111/j.1749-6632.2010.05829.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  81 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody.

Authors:  T Bizebard; R Daniels; R Kahn; B Golinelli-Pimpaneau; J J Skehel; M Knossow
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

3.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

Review 4.  Structural basis of immune recognition of influenza virus hemagglutinin.

Authors:  I A Wilson; N J Cox
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

6.  Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

Authors:  R B Couch; J A Kasel; J L Gerin; J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

7.  Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin.

Authors:  M Knossow; R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

9.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

10.  Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.

Authors:  M J Gething; R W Doms; D York; J White
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

View more
  43 in total

Review 1.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.

Authors:  Mengran Qian; Hongxing Hu; Teng Zuo; Guiqin Wang; Linqi Zhang; Paul Zhou
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

3.  Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets.

Authors:  Krista M McCutcheon; Julia Gray; Natalie Y Chen; Keyi Liu; Minha Park; Stote Ellsworth; Ralph A Tripp; S Mark Tompkins; Scott K Johnson; Shelly Samet; Lenore Pereira; Lawrence M Kauvar
Journal:  MAbs       Date:  2014-01-08       Impact factor: 5.857

4.  Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.

Authors:  Jason J Otterstrom; Boerries Brandenburg; Martin H Koldijk; Jarek Juraszek; Chan Tang; Samaneh Mashaghi; Ted Kwaks; Jaap Goudsmit; Ronald Vogels; Robert H E Friesen; Antoine M van Oijen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

5.  Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.

Authors:  Suman R Das; Scott E Hensley; Alexandre David; Loren Schmidt; James S Gibbs; Pere Puigbò; William L Ince; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

Review 6.  To dream the impossible dream: universal influenza vaccination.

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Virol       Date:  2013-07-05       Impact factor: 7.090

7.  A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.

Authors:  Yoko Shoji; R Mark Jones; Vadim Mett; Jessica A Chichester; Konstantin Musiychuk; Xiangjie Sun; Terrence M Tumpey; Brian J Green; Moneim Shamloul; Joey Norikane; Hong Bi; Caitlin E Hartman; Cory Bottone; Michelle Stewart; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

8.  Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.

Authors:  Yoko Shoji; Alex Prokhnevsky; Brett Leffet; Nancy Vetter; Stephen Tottey; Shama Satinover; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; R Mark Jones; Jessica A Chichester; Brian J Green; Stephen J Streatfield; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.

Authors:  Suman R Das; Scott E Hensley; William L Ince; Christopher B Brooke; Anju Subba; Mark G Delboy; Gustav Russ; James S Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

10.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.